Mesenchymal stem cells neither fully acquire the electrophysiological properties of mature cardiomyocytes nor promote ventricular arrhythmias in infarcted rats

Basic Research in Cardiology

Volumn 107, Issue 4, 2012, Pages

  Wei, Feng ^a   Wang, Ting Zhong ^a   Zhang, Jing ^a   Yuan, Zu Yi ^a   Tian, Hong Yan ^a   Ni, Ya Juan ^a   Zhuo, Xiao Zhen ^a   Han, Ke ^a   Liu, Yu ^a   Lu, Qun ^a   Bai, Hong Yuan ^a   Ma, Ai Qun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Arrhythmia; Cardiomyocyte; Electrophysiological property; Mesenchymal stem cell; Myocardial infarction

Indexed keywords

BIOLOGICAL MARKER; CALCIUM CHANNEL; CALCIUM CHANNEL CAV1.2; CALCIUM ION; CONNEXIN 43; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; MYH PROTEIN; POTASSIUM CHANNEL KV1.4; SODIUM CHANNEL NAV1.5; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CAV1.2 GENE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENGRAFTMENT; GENE; GENE EXPRESSION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE ARRHYTHMIA; KIR2.1 GENE; KV1.4 GENE; KV4.2 GENE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NAV1.5 GENE; NONHUMAN; POTASSIUM CURRENT; QRS COMPLEX; RAT; SODIUM CURRENT; ANIMAL; CYTOLOGY; ELECTROCARDIOGRAPHY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEART ARRHYTHMIA; LASER CAPTURE MICRODISSECTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; CELL DIFFERENTIATION; ELECTROCARDIOGRAPHY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; LASER CAPTURE MICRODISSECTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84862736754     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-012-0274-4     Document Type: Article

References (59)

1. Asp L, Beraki S, Kristensson K, Ogren SO, Karlsson H (2009) Neonatal infection with neurotropic influenza A virus affects working memory and expression of type III Nrg1 in adult mice. Brain Behav Immun 23:733-741. doi:10.1016/j.bbi.2009.04.004
2. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. New Engl J Med 355:1222-1232. doi:10.1056/ nejmoa051779
3. Beeres S, Zeppenfeld K, Bax JJ, Dibbets-Schneider P, Stokkel MPM, Fibbe WE, van der Wall EE, Atsma DE, Schalij MJ (2007) Electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease. Heart Rhythm 4:257-265. doi:10.1016/j. hrthm.2006.10.033
4. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P (2011) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 378:1847-1857. doi:10.1016/s0140-6736(11)61590-0
5. Briguori C, Reimers B, Sarais C, Napodano M, Pascotto P, Azzarello G, Bregni M, Porcellini A, Vinante O, Zanco P, Peschle C, Condorelli G, Colombo A (2006) Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J 151:674-680. doi: 10.1016/j.ahj.2005.04.033
6. Chang MG, Tung L, Sekar RB, Chang CY, Cysyk J, Dong PH, Marban E, Abraham R (2006) Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation 113:1832-1841. doi:10.1161/circulationaha. 105.593038
7. Chen SL, Fang W, Ye F, Liu YH, Qian J, Shan S, Zhang J, Zhao RCH, Liao LM, Lin S, Sun JP (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92-95. doi:10.1016/j.amjcard.2004. 03.034
8. Cho J, Zhai P,MaejimaY, SadoshimaJ (2011)Myocardial injection with GSK-3 beta-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction. Circ Res 108:478-489. doi:10.1161/circresaha. 110.229658
9. Du Y, Huang X, Wang T, Han K, Zhang J, Xi Y, Wu G, Ma A (2007) Downregulation of neuronal sodium channel subunits Nav1.1 and Nav1.6 in the sinoatrial node from volume-overloaded heart failure rat. Pflug Arch Eur J Phy 454:451-459. doi: 10.1007/s00424-007-0216-4
10. Enoki C, Otani H, Sato D, Okada T, Hattori R, Imamura H (2010) Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction. Int J Cardiol 138:9-18. doi:10.1016/j.ijcard. 2009.04.012
11. Fuchs S, Kornowski R, Weisz G, Satler LF, Smits PC, Okubagzi P, Baffour R, Aggarwal A, Weissman NJ, Cerqueira M, Waksman R, Serrruys P, Battler A, Moses JW, Leon MB, Epstein SE (2006) Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol 97:823-829. doi:10.1016/j.amjcard.2005.09.132
12. Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Felkin LE, Lee J, Barton PJR, Terracciano CMN, Yacoub MH, Suzuki K (2007) Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 115:2254-2261. doi:10.1161/circulationaha.106.662577
13. Gao E, Lei YH, Shang XY, Huang ZM, Zuo L, Boucher M, Fan QA, Chuprun JK, Ma XL, Koch WJ (2010) A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 107:1445-1453. doi:10.1161/circresaha.110. 223925
14. Grauss RW, van Tuyn J, Steendijk P, Winter EM, Pijnappels DA, Hogers B, Groot A, van der Geest R, van der Laarse A, de Vries AAF, Schalij MJ, Atsmaa DE (2008) Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts. Stem Cells 26:1083-1093. doi:10.1634/stemcells.2007-0523
15. Hagege AA, Marolleau JP, Vilquin JT, Alheritiere A, Peyrard S, Duboc D, Abergel E, Messas E, Mousseaux E, Schwartz K, Desnos M, Menasche P (2006) Skeletal myoblast transplantation in ischemic heart failure-long-term follow-up of the first phase I cohort of patients. Circulation 114:I108-I113. doi:10.1161/ circulationaha.105.000521
16. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB, Reisman MA, Schaer GL, Sherman W (2009) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54:2277-2286. doi:10.1016/j.jacc.2009.06.055
17. Heusch G (2011) SCIPIO brings new momentum to cardiac cell therapy. Lancet 378:1827-1828. doi:10.1016/s0140-6736(11) 61648-6
18. Huang J, Zhang ZP, Guo JA, Ni AG, Deb A, Zhang LN, Mirotsou M, Pratt RE, Dzau VJ (2010) Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res 106:1753-1762. doi:10.1161/circresaha. 109.196030
19. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kolantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F (2006) Autologous bone marrow-derived stemcell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 367:113-121. doi:10.1016/S0140-6736(05)67861-0
20. Jiang W, Ma A, Wang T, Han K, Liu Y, Zhang Y, Dong A, Du Y, Huang X, Wang J, Lei X, Zheng X (2006) Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: A time-series study. Pflug Arch Eur J Phy 453:43-52. doi:10.1007/s00424-006-0117-y
21. Jin JY, Jeong SI, Shin YM, Lim KS, Shin HS, Lee YM, Koh HC, Kim KS (2009) Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon- caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur J Heart Fail 11:147-153. doi:10.1093/eurjhf/hfn017
22. Katritsis DG, Sotiropoulou P, Giazitzoglou E, Karvouni E, PapamichailM(2007) Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace 9:167-171. doi:10.1093/europace/eul184
23. Li GR, Deng XL, Sun HY, Chung SSM, Tse HF, Lau CP (2006) Ion channels in mesenchymal stem cells from rat bone marrow. Stem Cells 24:1519-1528. doi:10.1634/stemcells.2005-0307
24. Li Q, Guo Y, Ou Q, Chen N, Wu WJ, Yuan F, O'Brien E, Wang T, Luo L, Hunt GN, Zhu X, Bolli R (2011) Intracoronary administration of cardiac stem cells in mice: A new, improved technique for cell therapy in murine models. Basic Res Cardiol 106:849-864. doi:10.1007/s00395-011-0180-1
25. Li WZ, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lutzow K, Lendlein A, Stamm C, Li RK, Steinhoff G (2007) Bc1-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25:2118-2127. doi:10.1634/stemcells.2006-0771
26. Lorenzen JM, Martino F, Thum T (2012) Epigenetic modifications in cardiovascular disease. Basic Res Cardiol 107:245. doi: 10.1007/s00395-012-0245- 9
27. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grogaard HK, Bjornerheim R, Brekke M, Muller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K (2006) Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. New Engl J Med 355:1199-1209. doi:10.1056/nejmoa055706
28. Lunde K, Solheim S, Forfang K, Arnesen H, Brinch L, Jornerheim R, Ragnarsson A, Egeland T, Endresen K, Ilebekk A, Mangschau A, Aakhus S (2008) Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells-safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. J Am Coll Cardiol 51:674-676. doi:10.1016/j.jacc.2007.10. 032
29. Ly HQ, Nattel S (2009) Stem cells are not proarrhythmic: Letting the genie out of the bottle. Circulation 119:1824-1831. doi: 10.1161/circulationaha. 108.812701
30. Macia E, Boyden PA (2009) Stem cell therapy is proarrhythmic. Circulation 119:1814-1823. doi:10.1161/circulationaha.108. 779900
31. Madonna R, Rokosh G, De Caterina R, Bolli R (2010) Hepatocyte growth factor/Met gene transfer in cardiac stem cells-potential for cardiac repair. Basic Res Cardiol 105:443-452. doi: 10.1007/s00395-010-0102-7
32. Mangi AA, Noiseux N, Kong DL, He HM, Rezvani M, Ingwall JS, Dzau VJ (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201. doi:10.1038/nm912
33. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41:1078-1083. doi: 10.1016/S0735-1097(03)00092-5
34. Mills W, Mal N, Kiedrowski M, Unger R, Forudi F, Popovic Z, Penn M, Laurita K (2007) Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol 42:304-314. doi:10.1016/j.yjmcc.2006.09.011
35. Numasawa Y, Kimura T, Miyoshi S, Nishiyama N, Hida N, Tsuji H, Tsuruta H, Segawa K, Ogawa S, Umezawa A (2011) Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis. Stem Cells 29:1405-1414. doi:10.1002/stem.691
36. Oerlemans MI, Goumans MJ, van Middelaar B, Clevers H, Doevendans PA, Sluijter JP (2010) Active Wnt signaling in response to cardiac injury. Basic Res Cardiol 105:631-641. doi: 10.1007/s00395-010-0100-9
37. Ohtani K, Dimmeler S (2011) Control of cardiovascular differentiation by microRNAs. Basic Res Cardiol 106:5-11. doi: 10.1007/s00395-010-0139-7
38. Orlandi A, Chavakis E, Seeger F, Tjwa M, Zeiher AM, Dimmeler S (2010) Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol 105:703-712. doi:10.1007/s00395-010-0109-0
39. Pak HN, Qayyum M, Kim DT, Hamabe A, Miyauchi Y, Lill MC, Frantzen M, Takizawa K, Chen LS, Fishbein MC, Sharifi BG, Chen PS, Makkar R (2003) Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a swine model of myocardial infarction. J Cardiovasc Electr 14:841-848. doi:10.1046/j.1540-8167.2003.03124.x
40. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M (2008) Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77:134-142. doi:10.1093/cvr/cvm025
41. Rosova I, Dao M, Capoccia B, Link D, Nolta JA (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26:2173-2182. doi:10.1634/ stemcells.2007-1104
42. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC (2010) In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28:788-798. doi:10.1002/stem.312
43. Sanganalmath SK, Abdel-Latif A, Bolli R, Xuan YT, Dawn B (2011) Hematopoietic cytokines for cardiac repair: Mobilization of bone marrow cells and beyond. Basic Res Cardiol 106:709-733. doi:10.1007/s00395-011-0183-y
44. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu JT, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM, Investigators R-A (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New Engl J Med 355:1210-1221. doi:10.1056/nejmoa060186
45. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu JT, Corti R, Mathey DG, Hamm CW, Suselbeck T, Werner N, Haase J, Neuzner J, Germing A, Mark B, Assmus B, Tonn T, Dimmeler S, Zeiher AM, Investigators RA (2006) Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial. Eur Heart J 27:2775-2783. doi:10.1093/eurheartj/ehl388
46. Shinmura D, Togashi I, Miyoshi S, Nishiyama N, Hida N, Tsuji H, Tsuruta H, Segawa K, Tsukada Y, Ogawa S, Umezawa A (2011) Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function. Stem Cells 29:357-366. doi: 10.1002/stem.574
47. Song H, Hwang HJ, Chang W, Song BW, Cha MJ, Kim IK, Lim S, Choi EJ, Ham O, Lee CY (2011) Cardiomyocytes from phorbol myristate acetate-activated mesenchymal stem cells restore electromechanical function in infarcted rat hearts. Proc Natl Acad Sci USA 108:296-301. doi:10.1073/pnas.1015873107
48. Stamm C, Kleine HD, Westphal B, Petzsch M, Kittner C, Nienaber CA, Freund M, Steinhoff G (2004) CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiov Surg 52:152-158. doi:10.1055/s-2004-817981
49. Tang YL, Tang Y, Zhang YC, Qian KP, Shen LP, Phillips I (2005) Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46:1339-1350. doi:10.1016/j.jacc. 2005.05.079
50. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93-98. doi: 10.1161/hc0102.101442
51. Tsuji H, Miyoshi S, Ikegami Y, Hida N, Asada H, Togashi I, Suzuki J, Satake M, Nakamizo H, Tanaka M, Mori T, Segawa K, Nishiyama N, Inoue J, Makino H, Miyado K, Ogawa S, Yoshimura Y, Umezawa A (2010) Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 106:1613-1623. doi:10.1161/circresaha.109.205260
52. Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B (1988) The lambeth conventionsguidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc Res 22:447-455. doi: 10.1093/cvr/22.7.447
53. Wang D, Zhang F, Shen W, Chen M, Yang B, Zhang Y, Cao K (2010) Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. Int J Cardiol 152:314-320. doi:10.1016/j.ijcard.2010.07.025
54. Wang SP, Wang JA, Luo RH, Cui WY, Wang H (2008) Potassium channel currents in rat mesenchymal stem cells and their possible roles in cell proliferation. Clin Exp Pharmacol Physiol 35:1077-1084. doi:10.1111/j.1440-1681. 2008.04964
55. Wang TZ, Xu ZY, Jiang WH, Ma AQ (2006) Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 109:74-81. doi: 10.1016/j.ijcard.2005.05.072
56. Wei F, Wang TZ, Liu JJ, Du Y, Ma AQ (2011) The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells. Exp Cell Res 317:2661-2670. doi:10.1016/j.yexcr.2011.08.011
57. White HD, Chew DP (2008) Acute myocardial infarction. Lancet 372:570-584. doi:10.1016/S0140-6736(08)61237-4
58. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364:141-148. doi:10.1016/S0140-6736(04)16626-9
59. Wu J, Li J, Zhang N, Zhang C (2011) Stem cell-based therapies in ischemic heart diseases: A focus on aspects of microcirculation and inflammation. Basic Res Cardiol 106:317-324. doi:10.1007/ s00395-011-0168-x